Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

(Cost)-Effectiveness of Intensive Trauma-Focused Treatment Versus Spaced Trauma-Focused Treatment As First Line Treatment for Post-Traumatic Stress Disorder in Adults with Multiple Trauma Exposure: Randomized Controlled Trial

NCT06700590 is registered in ClinicalTrials.gov with ARQ National Psychotrauma Centre as lead sponsor.

NCT NCT06700590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06700590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
(Cost)-Effectiveness of Intensive Trauma-Focused Treatment Versus Spaced Trauma-Focused Treatment As First Line Treatment for Post-Traumatic Stress Disorder in Adults with Multiple Trauma Exposure: Randomized Controlled Trial
Lead sponsor
ARQ National Psychotrauma Centre
Phase
Not applicable
Overall status
Recruiting
Start date
November 21, 2024
Completion date
July 1, 2028
Enrollment
186 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

ptsd - post traumatic stress disorder